With systemic analysis in genetic and transcriptional data, Huimei has identified the risk gene associated with fibrotic diseases, such as cardiac fibrosis, kidney fibrosis, and brain diseases. She tries to illustrate their roles involved with suitable In vitro and In vivo models. WWP2 is taken as a promising gene target and continued into drug development for tissue fibrosis.